Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a malaria transmission free area in Colombia

Memorias do Instituto Oswaldo Cruz

Volumn 97, Issue 4, 2002, Pages 559-562

  Castillo, Carmen Manuela ^a   Osorio, Lyda Elena ^a   Palma, Gloria Inès ^b  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Chloroquine; Colombia; Malaria; Plasmodium falciparum; Plasmodium vivax

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; CHILD; COLOMBIA; DRUG RESISTANCE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MALARIA; MALARIA FALCIPARUM; MALE; MIDDLE AGED;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHLOROQUINE; COLOMBIA; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED;

EID: 0036598263     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762002000400020     Document Type: Article

References (12)

1. Alecrim M, Alecrim W, Macedo V 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 32: 67-68.
2. Baird K, Martin G 1998. Clinical trial of chloroquine for treatment of uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax in Guyana, South America. 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC.
3. Blair S 1986. Resistencia del P. falciparum a drogas en Colombia. Biomédica 6: 95-99.
4. Espinal CA, Cortes GT, Guerra P, Arias AR 1985. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 34: 675-680.
5. Lemeshow S, Taber S 1991. Lot Quality Assurance sampling: single-and double-sampling plans. Wid hlth statis Quart: 115-129.
6. Ministerio de Salud 1998. Direccion de Campañas Directas y Oficina Sanitaria Panamericana (OPS/OMS), Bogota.
7. Ministerio de Salud 1999. Dirección General de Promoción y Prevención. Guía de Atención Clínica para el Diagnóstico y Tratamiento de la Malaria, Santa Fe de Bogota.
8. Osorio LE, Giraldo LE, Grajales LF, Arriaga AL, Andrade AL, Ruebush TK, Barat LM 1999. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimetamine in a low malaria transmission area in Colombia. Am J Trop Med Hyg 61: 968-972.
9. Padilla NP, Cordon R 1998. In vivo response of Plasmodium vivax and Plasmodium falciparum strains to chloroquine in Guatemala, Central America. 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC.
10. PAHO-Pan American Health Organization 1998. Assessment of therapeutic efficacy of chloroquine for uncomplicated vivax malaria. Working graft, Manaus, Brasil.
11. WHO-World Health Organization 1996. Division of Control of Tropical Diseases. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated P. falciparum Malaria in Areas with Intense Transmission. Geneva, WHO/ MAL/96.1077.
12. WHO-World Health Organization 2000. Expert Committee on Malaria. WHO Tech Rep Ser 892: 1-74.